GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Taiwan Biomaterial Co 6649.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

35.90

+4.06%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 220.4m

FY2016FY2025

Net income

TWD 58.9m

FY2016FY2025

Free cash flow

TWD 45.6m

FY2016FY2025

Shareholders' equity

TWD 685.1m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 220.4mTWD 96.6mTWD 72.8mTWD 127.3mTWD 41.7mTWD 18.1mTWD 16.5mTWD 1.0mTWD 1.9mTWD 1.6m
Gross profitTWD 134.8mTWD 57.3mTWD 47.1mTWD 90.4mTWD 32.1mTWD 14.7mTWD 14.3mTWD 391,000TWD 601,000TWD 518,000
Research and developmentTWD 23.6mTWD 31.1mTWD 22.8mTWD 32.1mTWD 65.4mTWD 56.5mTWD 59.8mTWD 44.6mTWD 38.3mTWD 27.0m
Operating incomeTWD 60.8m−TWD 11.2m−TWD 14.2mTWD 25.5m−TWD 56.7m−TWD 65.1m−TWD 73.1m−TWD 67.9m−TWD 53.0m−TWD 36.6m
Net incomeTWD 58.9m−TWD 1.7m−TWD 10.1mTWD 33.8m−TWD 47.4m−TWD 55.4m−TWD 71.3m−TWD 60.5m−TWD 49.6m−TWD 32.6m
Diluted earnings per share1.40-0.04-0.240.80-1.44-1.61-2.16-1.94-1.86-1.58

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 789.9mTWD 704.6mTWD 716.3mTWD 735.3mTWD 553.8mTWD 572.5mTWD 660.5mTWD 471.6mTWD 532.3mTWD 171.2m
Cash and short-term investments—————TWD 208.7mTWD 406.6mTWD 429.3mTWD 494.1mTWD 138.3m
Total liabilitiesTWD 104.9mTWD 78.4mTWD 88.4mTWD 88.9mTWD 130.9mTWD 103.4mTWD 136.1mTWD 9.3mTWD 11.5mTWD 5.8m
Debt—————TWD 76.2mTWD 76.1m———
Shareholders' equityTWD 685.1mTWD 626.2mTWD 627.9mTWD 646.4mTWD 422.9mTWD 469.0mTWD 524.4mTWD 462.3mTWD 520.8mTWD 165.4m
Shares outstanding42m42m42m42m33m34m33m31m27m21m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 48.8mTWD 18.4m−TWD 10.2mTWD 29.3m−TWD 26.3m−TWD 45.1m−TWD 64.7m−TWD 60.7m−TWD 42.3m−TWD 32.4m
Capital spending−TWD 3.1m−TWD 4.6m−TWD 3.2m−TWD 37.5m−TWD 29.7m−TWD 149.4m−TWD 90.2m−TWD 4.4m−TWD 1.4m−TWD 5.5m
Free cash flowTWD 45.6mTWD 13.8m−TWD 13.4m−TWD 8.2m−TWD 56.0m−TWD 194.5m−TWD 154.9m−TWD 65.1m−TWD 43.6m−TWD 37.9m
Dividends paid——−TWD 8.4m———————

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 36.9mTWD 26.4mTWD 46.2mTWD 72.8mTWD 33.8mTWD 67.6mTWD 29.1mTWD 27.5m
Gross profitTWD 18.0mTWD 16.0mTWD 24.0mTWD 44.0mTWD 19.4mTWD 47.3mTWD 15.9mTWD 15.6m
Operating income−TWD 3.1m−TWD 3.8m−TWD 199,000TWD 25.6mTWD 5.0mTWD 30.4m−TWD 1.8m−TWD 1.6m
Net incomeTWD 622,000TWD 138,000TWD 3.8mTWD 28.6m−TWD 6.5mTWD 33.0mTWD 1.7m−TWD 1.2m
Diluted earnings per share0.010.000.090.68-0.160.790.04-0.03
Cash from operations−TWD 51.0mTWD 1.0m−TWD 7.0mTWD 23.0m—TWD 32.0mTWD 15.0mTWD 11.0m
Capital spending−TWD 4.0m−TWD 1.0m−TWD 1.0m−TWD 1.0m——−TWD 1.0m−TWD 1.0m
Free cash flow−TWD 55.0mTWD 0−TWD 8.0mTWD 22.0m——TWD 14.0mTWD 10.0m
Total assetsTWD 731.1mTWD 772.6mTWD 789.9mTWD 767.1mTWD 724.1mTWD 732.2mTWD 704.6mTWD 697.7m
Shareholders' equityTWD 643.8mTWD 643.2mTWD 685.1mTWD 681.3mTWD 652.7mTWD 659.2mTWD 626.2mTWD 624.5m

Financial ratios

Data as of 1 Nov 2026

FY2025FY2024FY2023FY2022FY2021
Gross margin68.7%59.3%64.7%71.0%77.1%
Operating margin27.1%-1.7%-11.2%27.3%-136.1%
Net margin26.7%-1.8%-13.9%26.5%-113.8%
Return on equity8.6%-0.3%-1.6%5.2%-11.2%
Return on assets7.5%-0.2%-1.4%4.6%-8.6%
Revenue growth128.2%32.6%-42.8%205.5%—
Earnings growth-3502.2%-82.9%-130.0%-171.2%—
Current ratio8.53x14.39x11.30x13.74x2.77x
Equity ratio86.7%88.9%87.7%87.9%76.4%
Interest coverage80.52x-2.10x-9.36x35.69x-55.07x
R&D as a share of sales10.7%32.2%31.3%25.2%156.9%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue20.1%64.9%78.2%
Operating income33.7%——
Net income20.4%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin60.6%63.7%65.3%65.6%
Operating margin15.6%11.8%-10.6%-57.3%
Net margin18.0%15.6%-3.8%-47.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings33.1-829.3-129.843.2-17.3-17.8-17.1-24.4-35.9
Price to sales8.914.918.111.419.654.673.7——

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 9 Aug 2023.

FY2023
Paid in the year0.20

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.